News

Symbiomix, a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections, announced submission of a new drug application (NDA) for Solosec™…
Read More...

Ethypharm announced that it has signed a definitive agreement to acquire Martindale Pharma. Martindale Pharma is a leading UK-based specialty pharmaceutical company providing…
Read More...

Evotec AG announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly owned subsidiary of Asahi Kasei…
Read More...

Eli Lilly and Company and CoLucid Pharmaceuticals, Inc. announced an agreement for Lilly to acquire CoLucid for $46.50 per share or approximately $960 million. This all-cash transaction…
Read More...

Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc., a privately-held biopharmaceutical company committed to developing medicines that transform the lives of people with…
Read More...

MilliporeSigma announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component…
Read More...

Progenra, Inc. announced a new immune-oncology drug whose mechanism differs from available cancer immunotherapies Opdivo and Keytruda. The findings, published by Progenra with Dr. Wayne…
Read More...

Evotec AG and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP, a Toronto-based company focused on developing first-in-class therapeutics targeting fibrotic…
Read More...

Brazilian healthcare regulator Anvisa on Monday said it had issued the country's first license for sale of a cannabis-based drug in the country after years of legal wrangling with…
Read More...

Benitec Biopharma Limited is pleased to announce that the European Commission, based on a favourable recommendation from the European Medicines Agency (EMA) Committee for Orphan…
Read More...

The U.S. Supreme Court on Friday agreed to hear a dispute over whether companies that make copycat versions of biologic drugs must wait six months after winning federal approval to…
Read More...

Sunovion Pharmaceuticals Inc. (Sunovion) announced that results of a pivotal Phase 2/3 study (SEP360-202) evaluating novel drug candidate dasotraline in children ages 6 to 12 years with…
Read More...

Shionogi & Co., Ltd. has announced that cefiderocol (S-649266), a novel siderophore cephalosporin in late-stage development, met the FDA pre-specified primary endpoint for…
Read More...

Harrington Discovery Institute at University Hospitals in Cleveland, Ohio and the Alzheimer's Drug Discovery Foundation (ADDF) have expanded their collaboration to accelerate…
Read More...

Kitov Pharmaceuticals Holdings Ltd., an innovative biopharmaceutical company, announced the expansion of its pipeline through the acquisition of a majority stake in TyrNovo Ltd., a…
Read More...

Pharma major Lupin said that it has launched in the US market its generic version of morphine sulfate ER tablets used for management of severe pain. The company said it has launched…
Read More...

Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, announced that the United States Patent and Trademark Office (USPTO) has issued a patent entitled "Compositions…
Read More...

Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited announced that they have entered a collaboration to develop Maverick’s T-cell…
Read More...

Valeant Pharmaceuticals International, Inc. announced that its affiliate has entered into a definitive agreement to sell all of the outstanding equity interests in Dendreon…
Read More...

ViraCyte, LLC announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Viralym-C, ViraCyte's T cell immunotherapy product designed to treat…
Read More...